The investigators did not evaluate individual GLP-1 agents, duration of treatment, genetic predisposition, breast cancer subtype, or stage at diagnosis
Obesity The Phase 2 data showed weight loss results that exceeded both semaglutide and tirzepatide in head-to-head comparisons within the trial data
Notably, 34% of covering firms require lifestyle program participation (such as dietitian or case manager engagement), and 59% of firms with 5,000+ workers reported utilization was higher than expected ( [6] )
Cell-based experiments also demonstrate receptor-dependent signaling changes when GLP-RTinteracts with GLP-1R, GIPR, or GCGR expressing cells
Endogenous antioxidants cope with the oxidative burden and limit potential toxicity of ROS
It is important to approach these reviews with realistic expectations